{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:16:21Z","timestamp":1787930181234,"version":"build-2784847793"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["fertstertreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["F&amp;S Reports"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.xfre.2025.06.007","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T19:22:13Z","timestamp":1750965733000},"page":"394-398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence of endometrial hyperplasia and carcinoma in women with polycystic ovarian syndrome"],"prefix":"10.1016","volume":"6","author":[{"given":"Ravi","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3607-121X","authenticated-orcid":false,"given":"Frank Z.","family":"Stanczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Mandelbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Paulson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda K.","family":"McGinnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon A.","family":"Winer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xfre.2025.06.007_bib1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xfre.2025.06.007_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.01.001","article-title":"Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies","volume":"35","author":"Sanchez-Garrido","year":"2020","journal-title":"Mol Metab"},{"key":"10.1016\/j.xfre.2025.06.007_bib3","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.maturitas.2008.12.018","article-title":"Progestogen deficiency and endometrial cancer risk","volume":"62","author":"Schindler","year":"2009","journal-title":"Maturitas"},{"key":"10.1016\/j.xfre.2025.06.007_bib4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-0037-1603096","article-title":"Polycystic ovarian syndrome: long-term health consequences","volume":"35","author":"Zore","year":"2017","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.xfre.2025.06.007_bib5","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/ijc.27457","article-title":"Incidence rates of endometrial hyperplasia, endometrial cancer and hysterectomy from 1980 to 2003 within a large prepaid health plan","volume":"131","author":"Lacey","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.xfre.2025.06.007_bib6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"The behavior of endometrial hyperplasia. A long-term study of \"untreated\" hyperplasia in 170 patients","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.xfre.2025.06.007_bib7","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/cncr.21650","article-title":"Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study","volume":"106","author":"Trimble","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.xfre.2025.06.007_bib8","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/humrep\/des042","article-title":"Evaluating the association between endometrial cancer and polycystic ovary syndrome","volume":"27","author":"Haoula","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfre.2025.06.007_bib9","first-page":"2303","article-title":"Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study","volume":"21","author":"Fearnley","year":"2010","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.xfre.2025.06.007_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ygyno.2009.03.039","article-title":"Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship","volume":"114","author":"Fader","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.xfre.2025.06.007_bib11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2025.06.007_bib12","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2025.06.007_bib13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/humrep\/der396","article-title":"Consensus on women's health aspects of polycystic ovary syndrome (PCOS)","volume":"27","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfre.2025.06.007_bib14","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.xfre.2025.06.007_bib15","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/clinchem\/hvaa117","article-title":"Sample multiplexing: increased throughput for quantification of total testosterone in serum by liquid chromatography-tandem mass spectrometry","volume":"66","author":"Colletti","year":"2020","journal-title":"Clin Chem"},{"key":"10.1016\/j.xfre.2025.06.007_bib16","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.fertnstert.2013.12.056","article-title":"Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria","volume":"101","author":"Salameh","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2025.06.007_bib17","first-page":"325","article-title":"Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome","volume":"98","author":"Cheung","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.xfre.2025.06.007_bib18","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1016\/j.fertnstert.2011.04.022","article-title":"Endometrial thickness predicts endometrial hyperplasia in patients with polycystic ovary syndrome","volume":"95","author":"McCormick","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2025.06.007_bib19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.AOG.0000154151.14516.f7","article-title":"Risk factors for young premenopausal women with endometrial cancer","volume":"105","author":"Soliman","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.xfre.2025.06.007_bib20","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00007611-200105000-00020","article-title":"Endometrial adenocarcinoma and polycystic ovary syndrome: risk factors, management, and prognosis","volume":"94","author":"Elliott","year":"2001","journal-title":"South Med J"},{"key":"10.1016\/j.xfre.2025.06.007_bib21","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ygyno.2014.01.004","article-title":"Hyperinsulinemia is associated with endometrial hyperplasia and disordered proliferative endometrium: a prospective cross-sectional study","volume":"132","author":"Shan","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.xfre.2025.06.007_bib22","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0188-4409(01)00325-3","article-title":"Mechanisms of hypothalamic-pituitary-gonadal disruption in polycystic ovarian syndrome","volume":"32","author":"Barontini","year":"2001","journal-title":"Arch Med Res"},{"key":"10.1016\/j.xfre.2025.06.007_bib23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bpobgyn.2016.03.005","article-title":"Hypothalamic-pituitary, ovarian and adrenal contributions to polycystic ovary syndrome","volume":"37","author":"Baskind","year":"2016","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.xfre.2025.06.007_bib24","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.fertnstert.2023.07.025","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"120","author":"Teede","year":"2023","journal-title":"Fertil Steril"}],"container-title":["F&amp;S Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666334125001011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666334125001011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T09:28:08Z","timestamp":1758619688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666334125001011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2666334125001011"],"URL":"https:\/\/doi.org\/10.1016\/j.xfre.2025.06.007","relation":{},"ISSN":["2666-3341"],"issn-type":[{"value":"2666-3341","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of endometrial hyperplasia and carcinoma in women with polycystic ovarian syndrome","name":"articletitle","label":"Article Title"},{"value":"F&S Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xfre.2025.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of American Society for Reproductive Medicine.","name":"copyright","label":"Copyright"}]}}